International Flavors & Fragrances Inc. IFF
92.18 USD -2.45 (-2.59%)
At closeNov 3, 2026, 4:00 PM EST
89.00 -3.18 -3.45%
After hours · Nov 3, 4:00 PM ET
91.65 Day range 94.86
61.30 52-week range 95.27
- YTD
- +36.79%
- 1 year
- +48.49%
Analyst view
Consensus: buy
Buy
Price target (mean) 97.47 +5.7% upside
Now 92.18
- Target (low)
- 76.00
- Target (mean)
- 97.47
- Target (high)
- 110.00
Ratings (0m) 20 14 buy · 6 hold · 0 sell
- Strong buy4
- Buy10
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 20
- 1 month ago 20
- 2 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.81533 | 0.75826 – 0.98 | 1.05 | -22.4% | 1.91B | -29.2% | 15 |
| Next quarter | 0.70157 | 0.51 – 1.09 | 0.80 | -12.3% | 1.82B | -29.7% | 14 |
| Current year | 3.21 | 3.08 – 3.48 | 4.20 | -23.5% | 7.59B | -30.3% | 14 |
| Next year | 3.93 | 3.40 – 4.69 | 3.21 | +22.2% | 7.84B | +3.3% | 18 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 16, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 7, 2026 | Argus Research | Maintained | Buy | Buy |
| Sep 11, 2026 | Keybanc | Initiated | — | Sector Weight |
| Aug 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2026 | Benchmark | Maintained | Buy | Buy |
| Jul 1, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 30, 2026 | Argus Research | Maintained | Buy | Buy |
| Jun 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Jun 9, 2026 | Benchmark | Initiated | — | Buy |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 7, 2026 | Citigroup | Maintained | Buy | Buy |
| May 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 7, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 17, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 17, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 13, 2026 | Oppenheimer | Upgrade | Perform | Outperform |
| Feb 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jan 22, 2026 | Argus Research | Maintained | Buy | Buy |
| Jan 21, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Nov 7, 2025 | Barclays | Maintained | Overweight | Overweight |